11/13
08:11 am
medp
Medpace (NASDAQ:MEDP) is now covered by analysts at BMO Capital Markets. They set a "market perform" rating and a $600.00 price target on the stock.
Low
Report
Medpace (NASDAQ:MEDP) is now covered by analysts at BMO Capital Markets. They set a "market perform" rating and a $600.00 price target on the stock.
11/13
04:28 am
medp
Rating for MEDP
Low
Report
Rating for MEDP
11/13
04:28 am
medp
Rating for MEDP
Low
Report
Rating for MEDP
11/12
04:11 pm
medp
Medpace initiated with a Market Perform at BMO Capital
Low
Report
Medpace initiated with a Market Perform at BMO Capital
11/12
04:11 pm
medp
Medpace initiated with a Market Perform at BMO Capital
Low
Report
Medpace initiated with a Market Perform at BMO Capital
10/24
09:45 am
medp
Rating for MEDP
Low
Report
Rating for MEDP
10/24
09:45 am
medp
Rating for MEDP
Low
Report
Rating for MEDP
10/24
09:24 am
medp
Rating for MEDP
Medium
Report
Rating for MEDP
10/24
09:24 am
medp
Rating for MEDP
Medium
Report
Rating for MEDP
10/17
09:23 am
medp
Rating for MEDP
Low
Report
Rating for MEDP
10/17
09:23 am
medp
Rating for MEDP
Low
Report
Rating for MEDP
10/2
07:27 am
medp
Rating for MEDP
Low
Report
Rating for MEDP
10/2
07:27 am
medp
Rating for MEDP
Low
Report
Rating for MEDP
10/2
06:21 am
medp
Medpace downgraded to Underweight from Equal Weight at Barclays
Low
Report
Medpace downgraded to Underweight from Equal Weight at Barclays
10/2
06:21 am
medp
Medpace downgraded to Underweight from Equal Weight at Barclays
Low
Report
Medpace downgraded to Underweight from Equal Weight at Barclays
9/9
07:05 am
medp
Rating for MEDP
Low
Report
Rating for MEDP
9/9
07:05 am
medp
Rating for MEDP
Low
Report
Rating for MEDP